BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16775668)

  • 1. Effects of withdrawal of Xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with coronary artery disease.
    Hu CL; Li YB; Tang YH; Chen JB; Liu J; Tang QZ; Zhang QH; Huang CX
    Cardiovasc Drugs Ther; 2006 Jun; 20(3):185-91. PubMed ID: 16775668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of xuezhikang at different doses on patients suffering from acute coronary syndrome after percutaneous coronary intervention].
    Jiang FY; Sun LP; Yang J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Dec; 31(12):1607-10. PubMed ID: 22384544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with stable angina.
    Li JJ; Hu SS; Fang CH; Hui RT; Miao LF; Yang YJ; Gao RL
    Clin Chim Acta; 2005 Feb; 352(1-2):217-24. PubMed ID: 15653117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia.
    Li JJ; Li YS; Chu JM; Zhang CY; Wang Y; Huang Y; Chen J; Yuan JQ; Huang YL
    Clin Chim Acta; 2006 Apr; 366(1-2):269-73. PubMed ID: 16343471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of Xuezhikang on serum levels of high sensitive-C reactive protein, matrix metalloproteinase-9 and lipoprotein in patients with acute coronary syndrome].
    Huang J; Wang MH; Peng XP; Wei C; Lu J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Mar; 26(3):221-3. PubMed ID: 16613266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Xuezhikang in patients with dyslipidemia: a multicenter, randomized, placebo-controlled study.
    Moriarty PM; Roth EM; Karns A; Ye P; Zhao SP; Liao Y; Capuzzi DM; Bays HE; Zhang F; Liu S; Reichman AJ; Brusco OA; Lu G; Lerman S; Duan Z; Guo S; Liu PL; Zhao J; Zhang Y; Li S
    J Clin Lipidol; 2014; 8(6):568-575. PubMed ID: 25499939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of withdrawal of statin on C-reactive protein.
    Lee KT; Lai WT; Chu CS; Tsai LY; Yen HW; Voon WC; Sheu SH
    Cardiology; 2004; 102(3):166-70. PubMed ID: 15334028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease.
    Zhao SP; Liu L; Cheng YC; Shishehbor MH; Liu MH; Peng DQ; Li YL
    Circulation; 2004 Aug; 110(8):915-20. PubMed ID: 15313947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term effects of xuezhikang, an extract of cholestin, on serum proprotein convertase subtilisin/kexin type 9 levels.
    Jia YJ; Zhang Y; Liu J; Guo YL; Xu RX; Li JJ
    Chin J Integr Med; 2016 Feb; 22(2):96-100. PubMed ID: 24993334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of Guizhi Fuling Decoction on YKL-40 and hs-CRP of patients with non-ST segment elevation acute coronary syndrome].
    Pei Q; Sang WF; Zhao XD
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Feb; 33(2):186-90. PubMed ID: 23646472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of xuezhikang on blood lipids, serum oxidized low density lipoprotein, C-reactive protein and fibrinogen in patients with unstable angina pectoris].
    Yao QH; Cui CC; Wang JK
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Oct; 23(10):750-2. PubMed ID: 14626188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction.
    Lu Z; Kou W; Du B; Wu Y; Zhao S; Brusco OA; Morgan JM; Capuzzi DM; ; Li S
    Am J Cardiol; 2008 Jun; 101(12):1689-93. PubMed ID: 18549841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
    Bays HE; Davidson M; Jones MR; Abby SL
    Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of triangle drugs as ginseng, Trichosanthes kirilowii maxim and rhubarb on the level of blood lipids and related pro-inflammatory cytokines during the process of treating atherosclerosis].
    Wang JY; Wu SX; Jiang LD
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 May; 31(5):667-71. PubMed ID: 21812271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xuezhikang, an extract of cholestin, decreases plasma inflammatory markers and endothelin-1, improve exercise-induced ischemia and subjective feelings in patients with cardiac syndrome X.
    Li JJ; Wang Y; Nie SP; Li Q; Li YS; Huang Y; Hui RT
    Int J Cardiol; 2007 Oct; 122(1):82-4. PubMed ID: 17196275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term effects of atorvastatin on C-reactive protein.
    Riesen WF; Engler H; Risch M; Korte W; Noseda G
    Eur Heart J; 2002 May; 23(10):794-9. PubMed ID: 12009719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of xuezhlkang capsule in intervening different Chinese medical syndrome patterns of non-alcoholic fatty liver disease complicated with carotid atherosclerosis].
    Ou MY; Xu SH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Feb; 31(2):159-63. PubMed ID: 21425565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
    Feldman T; Davidson M; Shah A; Maccubbin D; Meehan A; Zakson M; Tribble D; Veltri E; Mitchel Y
    Clin Ther; 2006 Jun; 28(6):849-59. PubMed ID: 16860168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of jingtian tongmai recipe on atherosclerotic plaque in rabbits].
    Zhao CX; Kasimu R; Wang XM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Feb; 29(2):136-9. PubMed ID: 19382474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.